SANUWAVE Announces 24-Week Data From Its Pivotal Trials Investigating the Use of dermaPACE Biotech Investing
BioLineRx Initiates Phase 2 Trial for BL-8040 as Novel Stem Cell Mobilization Treatment Biotech Investing
Naturally Splendid Award Finalist for HempOmega POS BioSciences Receives Prestigious Award Biotech Investing
Metabolix to Highlight Use of Mirel PHA Biopolymers as Performance Modifiers in PLA Applications Biotech Investing
Bion Environmental Technologies: Bringing Environmental and Sustainable Change to the Livestock Industry Agriculture Investing
ContraVir Initiates Phase 1/2a Clinical Study of CMX157 for Treating Chronic Hepatitis B Infection Biotech Investing
CymaBay Therapeutics Reports Positive Results from its Pilot Phase 2 Clinical Study of MBX-8025 Biotech Investing
